Overview
- Editors:
-
-
Benjamin Winograd
-
EORTC New Drug Development Office, Free University Hospital, Amsterdam, The Netherlands
-
Michael Peckham
-
Central Office, British Postgraduate Medical Federation, London, UK
-
Herbert Michael Pinedo
-
Department of Oncology, Free University Hospital, Amsterdam, The Netherlands
Access this book
Other ways to access
Table of contents (36 papers)
-
-
Human Tumour Xenografts in the Development of Biological Response Modifiers
-
-
-
- M. V. Pimm, J. A. Clegg, M. C. Garnett, R. W. Baldwin
Pages 95-98
-
- R. J. Fergusson, J. F. Smyth
Pages 99-102
-
- H. E. Blythman, A. Bord, I. Buisson, O. Thurneyssen, G. Richer, F. K. Jansen
Pages 103-107
-
Human Tumour Xenografts in Drug Screening
-
Front Matter
Pages 109-109
-
- B. Winograd, M. W. Lobbezoo, H. M. Pinedo
Pages 111-114
-
- R. H. Shoemaker, T. L. McLemore, B. J. Abbott, D. L. Fine, E. Gorelik, J. G. Mayo et al.
Pages 115-120
-
Importance of Drug Resistance in Screening
-
Front Matter
Pages 121-121
-
-
- S. Merry, D. Cunningham, E. R. Courtney, T. Hamilton, S. B. Kaye, R. I. Freshney
Pages 127-130
-
Proferred Papers at the E.S.O. Seminar
-
Front Matter
Pages 131-131
-
-
- F. Darcel, M. Chatel, V. Quemener, J. Ph. Moulinoux
Pages 134-134
-
- R. J. Fergusson, L. E. Anderson, J. F. Smyth
Pages 135-135
-
- G. L. Floersheim, A. Bieri, N. Chiodetti
Pages 135-136
-
- Ø. Fodstad, S. Aamdal, R. H. Shoemaker, A. Pihl
Pages 136-136
-
- W. Hinkelbein, A. Wuerdinger, E. Wallbrecher, H. H. Fiebig
Pages 137-137
-
- J. Hoogenhout, C. R. Jerusalem, J. J. M. Van Gasteren, H. B. Kal
Pages 137-138
About this book
Starting in 1986, the European School of Oncology has expanded its activities in post graduate teaching, which consisted mainly of traditional disease-orientated courses, by promoting new educational initiatives. One of these is the cloister seminars, short meet ings intended for highly qualified oncologists and dealing with specific, controversial aspects of clinical practice and research. Another is the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on developments and treatment in specific fields of oncology. This series of ESO Monographs was designed with the specific purpose of disseminat ing the results of the most interesting of the seminars and study groups, and providing concise and updated reviews of the subjects discussed. It was decided to keep the layout very simple in order to keep costs to a minimum and make the monographs available in the shortest possible time, thus overcoming a com mon problem in medical literature: that of the material being outdated even before publication. Umberto Veronesi Chairman, Scientific Committee European School of Oncology Position Paper on the Application of Human Tumour Xenografts as a Model for Preclinical Phase" Studies in the Evaluation of New Anticancer Compounds Outcome of a seminar on Human Tumour Xenografts organised by the European School of Oncology, Milan, 26th-27th May, 1986.
Editors and Affiliations
-
EORTC New Drug Development Office, Free University Hospital, Amsterdam, The Netherlands
Benjamin Winograd
-
Central Office, British Postgraduate Medical Federation, London, UK
Michael Peckham
-
Department of Oncology, Free University Hospital, Amsterdam, The Netherlands
Herbert Michael Pinedo